Biogen Wants MS Drug Approved Globally, CEO Says
April 15 (Bloomberg) -- George Scangos, chief executive officer of Biogen Idec Inc., talks about the drugmaker's first multiple sclerosis pill Tecfidera and the company's drug pipeline. He speaks with Betty Liu on Bloomberg Television's "In the Loop." (Source: Bloomberg)
Most Recent Videos
Jon Stanton to Succeed Keith Cochrane as Weir Group CEO
07:59 - Keith Cochrane, the CEO of Weir Group Plc, the world’s largest maker of fracking pumps for oil companies, is stepping down as CEO after 10 years on the board and will be replaced by Jon Stanton with effect from October 1. The company earlier reported that orders and sales missed by 4% and 2% respectively. Cochrane spoke to Bloomberg's Anna Edwards and Manus Cranny on "Countdown."